Pearl, the global frontrunner in dental artificial intelligence, has announced a groundbreaking $58 million Series B funding round, marking the largest investment ever in dental AI. The funding, led by Left Lane Capital with participation from Smash Capital, Alpha Partners, and existing investors Craft Ventures and Neotribe Ventures, aims to accelerate Pearl's mission of elevating patient care in dentistry worldwide.
The substantial investment will enable Pearl to expand its line of dental AI products, broaden its regulatory and patent portfolio, and increase global access to AI's transformative benefits in dentistry. Pearl's machine learning and computer vision tools address a critical challenge in the field; inconsistency in diagnostic accuracy, which directly impacts patient care quality.
Since receiving the first-ever FDA clearance for AI software to detect multiple pathologies in dental x-rays, Pearl's clinical AI has gained regulatory authorizations for chairside use in over 120 countries and recognition among TIME's Best Inventions. The company plans to use the new funding to accelerate the development of computer vision capabilities and introduce new AI tools to improve patient treatment planning, insurance claim approvals, and dental education.



